Piper Jaffray Upgrades AtriCure (ATRC) to Neutral; DoJ Resolution Clearly a Positive
Tweet Send to a Friend
Piper Jaffray & Co. upgrades AtriCure, Inc. (Nasdaq: ATRC) from Underweight to Neutral. Price target increased from $4 to $5.25 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
